{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T10:10:23Z","timestamp":1718878223250},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["anesthesiology.theclinics.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anesthesiology Clinics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.anclin.2016.06.003","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T07:15:49Z","timestamp":1478157349000},"page":"659-668","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coexisting Cardiac and Hematologic Disorders"],"prefix":"10.1016","volume":"34","author":[{"given":"Jordan E.","family":"Goldhammer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin A.","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anclin.2016.06.003_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajh.21569","article-title":"Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease","volume":"85","author":"Fitzhugh","year":"2010","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.anclin.2016.06.003_bib2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/pbc.21973","article-title":"Prolonged QTc interval in children and young adults with sickle cell disease at steady state","volume":"52","author":"Liem","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"13","key":"10.1016\/j.anclin.2016.06.003_bib3","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2011.10.900","article-title":"Cardiovascular abnormalities in sickle cell disease","volume":"59","author":"Gladwin","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.anclin.2016.06.003_bib4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacc.2006.09.038","article-title":"Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease","volume":"49","author":"Sachdev","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.anclin.2016.06.003_bib5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJMp038250","article-title":"Pulmonary hypertension in sickle cell disease","volume":"350","author":"Vichinsky","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.anclin.2016.06.003_bib6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2141.2012.09143.x","article-title":"Sickle-cell disease and the heart: Review of the current literature","volume":"157","author":"Voskaridou","year":"2012","journal-title":"Br J Haematol"},{"issue":"9557","key":"10.1016\/j.anclin.2016.06.003_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0140-6736(07)60114-7","article-title":"Myocardial infarction in sickle-cell disease","volume":"369","author":"Pavlu","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.anclin.2016.06.003_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/HPC.0b013e3181668ac3","article-title":"Acute myocardial infarction in sickle cell disease: a systematic review","volume":"7","author":"Pannu","year":"2008","journal-title":"Crit Pathw Cardiol"},{"issue":"9870","key":"10.1016\/j.anclin.2016.06.003_bib9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(12)61726-7","article-title":"The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial","volume":"381","author":"Howard","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.anclin.2016.06.003_bib10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1056\/NEJM199507273330402","article-title":"A\u00a0comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. the preoperative transfusion in sickle cell disease study group","volume":"333","author":"Vichinsky","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.anclin.2016.06.003_bib11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/icvts\/ivu249","article-title":"Hypothermic cardiopulmonary bypass without exchange transfusion in sickle-cell patients: a matched-pair analysis","volume":"19","author":"Edwin","year":"2014","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"1","key":"10.1016\/j.anclin.2016.06.003_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCULATIONAHA.109.882464","article-title":"Open heart surgery in patients with sickle cell hemoglobinopathy","volume":"121","author":"Yousafzai","year":"2010","journal-title":"Circulation"},{"issue":"49","key":"10.1016\/j.anclin.2016.06.003_bib13","first-page":"1155","article-title":"Incidence of sickle cell trait\u2013united states, 2010","volume":"63","author":"Ojodu","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.anclin.2016.06.003_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1532-5415.2011.03391.x","article-title":"Informing clinical practice guideline development and implementation: Prevalence of coexisting conditions among adults with coronary heart disease","volume":"59","author":"Boyd","year":"2011","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"5","key":"10.1016\/j.anclin.2016.06.003_bib15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jacc.2004.05.070","article-title":"Anemia as a risk factor and therapeutic target in heart failure","volume":"44","author":"Felker","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.anclin.2016.06.003_bib16","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0735-1097(00)00613-6","article-title":"The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations","volume":"35","author":"Silverberg","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9034","key":"10.1016\/j.anclin.2016.06.003_bib17","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(96)04330-9","article-title":"Effect of anaemia and cardiovascular disease on surgical mortality and morbidity","volume":"348","author":"Carson","year":"1996","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.anclin.2016.06.003_bib18","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ahj.2013.03.001","article-title":"Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease","volume":"165","author":"Carson","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.anclin.2016.06.003_bib19","doi-asserted-by":"crossref","first-page":"h3037","DOI":"10.1136\/bmj.h3037","article-title":"Harms associated with single unit perioperative transfusion: retrospective population based analysis","volume":"350","author":"Whitlock","year":"2015","journal-title":"BMJ"},{"issue":"26","key":"10.1016\/j.anclin.2016.06.003_bib20","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1012452","article-title":"Liberal or restrictive transfusion in high-risk patients after hip surgery","volume":"365","author":"Carson","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.anclin.2016.06.003_bib21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.7326\/0003-4819-159-11-201312030-00007","article-title":"Treatment of anemia in patients with heart disease: a systematic review","volume":"159","author":"Kansagara","year":"2013","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.anclin.2016.06.003_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199902113400601","article-title":"A\u00a0multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. transfusion requirements in critical care investigators, canadian critical care trials group","volume":"340","author":"Hebert","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.anclin.2016.06.003_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00003246-200102000-00001","article-title":"Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?","volume":"29","author":"Hebert","year":"2001","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.anclin.2016.06.003_bib24","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.amjcard.2011.06.014","article-title":"Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT randomized pilot study)","volume":"108","author":"Cooper","year":"2011","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.anclin.2016.06.003_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1365-2796.1998.00314.x","article-title":"Acute coronary disease in essential thrombocythemia and polycythemia vera","volume":"244","author":"Rossi","year":"1998","journal-title":"J\u00a0Intern Med"},{"issue":"4 Pt 2","key":"10.1016\/j.anclin.2016.06.003_bib26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-2006-942758","article-title":"Risk factors for thrombosis and bleeding and their influence on therapeutic decisions in patients with essential thrombocythemia","volume":"32","author":"Griesshammer","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1016\/j.anclin.2016.06.003_bib27","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","article-title":"Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia","volume":"8","author":"Cortelazzo","year":"1990","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"10.1016\/j.anclin.2016.06.003_bib28","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","article-title":"Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis","volume":"332","author":"Cortelazzo","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.anclin.2016.06.003_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006503.pub3","article-title":"Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia","author":"Squizzato","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.anclin.2016.06.003_bib30","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3324\/haematol.2009.018390","article-title":"Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom general practice research database","volume":"95","author":"Sarpatwari","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.anclin.2016.06.003_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1510\/icvts.2011.271296","article-title":"Idiopathic thrombocytopenic purpura and coronary artery disease: comparison between coronary artery bypass grafting and percutaneous coronary intervention","volume":"13","author":"Russo","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.anclin.2016.06.003_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-02-2012-5802","article-title":"Coronary artery stenting in a patient with chronic immune thrombocytopenic purpura: A clinical conundrum","volume":"2012","author":"Chan Wah Hak","year":"2012","journal-title":"BMJ Case Rep"},{"issue":"8","key":"10.1016\/j.anclin.2016.06.003_bib33","first-page":"789","article-title":"Severe thrombocytopenia refractory to platelet transfusions, secondary to abciximab readministration, in a patient previously diagnosed with idiopathic thrombocytopenic purpura. A possible etiopathogenic link","volume":"57","author":"Mendez","year":"2004","journal-title":"Rev Esp Cardiol"},{"issue":"4","key":"10.1016\/j.anclin.2016.06.003_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1590\/S0066-782X2005000400012","article-title":"Percutaneous transluminal coronary angioplasty in a patient with idiopathic thrombocytopenic purpura","volume":"84","author":"Marques","year":"2005","journal-title":"Arq Bras Cardiol"},{"issue":"2","key":"10.1016\/j.anclin.2016.06.003_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ajh.2830500203","article-title":"Increasing mortality from thrombotic thrombocytopenic purpura in the united states\u2013analysis of national mortality data, 1968-1991","volume":"50","author":"Torok","year":"1995","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.anclin.2016.06.003_bib36","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.281.9.806","article-title":"Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT investigators. evaluation of platelet IIb\/IIIa inhibitor for stenting","volume":"281","author":"Steinhubl","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.anclin.2016.06.003_bib37","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1136\/hrt.2004.049122","article-title":"Subacute coronary stent thrombosis in a patient developing clopidogrel associated thrombotic thrombocytopenic purpura","volume":"91","author":"von Mach","year":"2005","journal-title":"Heart"},{"issue":"23","key":"10.1016\/j.anclin.2016.06.003_bib38","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1161\/CIR.0000000000000031","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American heart association task force on practice guidelines","volume":"129","author":"Nishimura","year":"2014","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1016\/j.anclin.2016.06.003_bib39","doi-asserted-by":"crossref","first-page":"e576S","DOI":"10.1378\/chest.11-2305","article-title":"Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Whitlock","year":"2012","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.anclin.2016.06.003_bib40","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC)","year":"2012","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.anclin.2016.06.003_bib41","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archneur.57.12.1710","article-title":"Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk","volume":"57","author":"Phan","year":"2000","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.anclin.2016.06.003_bib42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.115.015242","article-title":"Pregnancy in women with a mechanical heart valve: Data of the european society of cardiology registry of pregnancy and cardiac disease (ROPAC)","volume":"132","author":"van Hagen","year":"2015","journal-title":"Circulation"},{"issue":"4 Suppl","key":"10.1016\/j.anclin.2016.06.003_bib43","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.healun.2010.01.011","article-title":"Clinical management of continuous-flow left ventricular assist devices in advanced heart failure","volume":"29","author":"Slaughter","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.anclin.2016.06.003_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11239-014-1162-6","article-title":"Management of anticoagulation and antiplatelet therapy in patients with left ventricular assist devices","volume":"39","author":"Baumann Kreuziger","year":"2015","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"7","key":"10.1016\/j.anclin.2016.06.003_bib45","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.healun.2012.02.023","article-title":"Non-cardiac surgery in patients on long-term left ventricular assist device support","volume":"31","author":"Morgan","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"12","key":"10.1016\/j.anclin.2016.06.003_bib46","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.108.801753","article-title":"Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial","volume":"119","author":"Massie","year":"2009","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.anclin.2016.06.003_bib47","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","article-title":"Warfarin and aspirin in patients with heart failure and sinus rhythm","volume":"366","author":"Homma","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.anclin.2016.06.003_bib48","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejheart.2006.02.012","article-title":"Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study","volume":"8","author":"Cokkinos","year":"2006","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.anclin.2016.06.003_bib49","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/1060028013511058","article-title":"Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal","volume":"48","author":"Prom","year":"2014","journal-title":"Ann Pharmacother"}],"container-title":["Anesthesiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1932227516300301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1932227516300301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T09:49:22Z","timestamp":1718876962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1932227516300301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1932227516300301"],"URL":"https:\/\/doi.org\/10.1016\/j.anclin.2016.06.003","relation":{},"ISSN":["1932-2275"],"issn-type":[{"value":"1932-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coexisting Cardiac and Hematologic Disorders","name":"articletitle","label":"Article Title"},{"value":"Anesthesiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anclin.2016.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}